text.skipToContent text.skipToNavigation
Need help? Please contact us
Pharma & Biotech

You searched for "x-vivo"

164 Products found
Too many choices? Use the filter option on the left to narrow your product listing.
  • PyroCell<sup>TM</sup> Monocyte Activation Test (MAT) Kit
    PyroCellTM Monocyte Activation Test (MAT) Kit

    PyroCellTM Monocyte Activation Test (MAT) Kit qualified for the monocyte activation test including 3 vials pooled PBMC (pMAT cells, 4 donors) as well as  3 vials of Cell Culture Medium Supplement for 3 x 96-well ELISA plates.

    Catalog #: 00249735
    Sales unit: kit
    Compare
    SA
  • Gentamicin Sulfate
    Gentamicin Sulfate

    Gentamicin Sulfate, 50 mg/mL, 1 x 10 mL (srew cap vial) 

     

    Please note: this product is no longer available in Europe and Africa.

    For customers in the Americas and Asia-Pacific regions, the product will be discontinued by June 30, 2022. It will be sold until stock is depleted.

    Catalog #: 17-518Z
    Sales unit: each
    Compare
    EA
  • Gentamicin for Cell Culture
    Gentamicin for Cell Culture

    Gentamicin for Cell Culture, 10 mg/mL, 10 x 10mL (screw cap vial).

     

    Please note: this product is no longer available in Europe and Africa.

    For customers in the Americas and Asia-Pacific regions, the product will be discontinued by June 30, 2022. It will be sold until stock is depleted.

    Catalog #: 17-519L
    Sales unit: each
    Compare
    EA
  • TheraPEAK™ MSCGM™ Supplement, 5ml
    TheraPEAK™ MSCGM™ Supplement, 5ml
    TheraPEAKTM MSCGMTM Mesenchymal Stem Cell Growth Medium Supplement is a GMP-produced, serum-free cell culture medium supplement, 2 x 5mL
    Catalog #: BEBP13-935Z5
    Sales unit: each
    Compare
    EA
  • 7
  • 8
  • 9(current)

You searched for "x-vivo"

763 Documents found
  • References - X-Vivo™
    Overview of relevant references
  • TechSheet - X-VIVO™ Media Systems
    Instructions for how to use the X-VIVO™ Media Series
  • X-VIVO™ Media use for Car-T
    Overview recent publications
  • TheraPEAK® X-VIVO® Hematopoietic Cell Culture Medium
    Serum-free, GMP produced medium for cell therapy applications
  • Quasi Vivo® QV500 User Manual
    Instructions for using and optimizing Quasi Vivo® QV500 cell culture fluidics system.
  • Quasi Vivo® QV900 User Manual
    Instructions for using and optimizing the Quasi Vivo® QV900 cell culture system.
  • Quasi Vivo® QV600 ALI User Manual
    Instructions for using and optimizing Quasi Vivo® QV600 Air-Liquid interface cell culture system
  • Quasi Vivo® QV600 LLI User Manual
    Instructions for using and optimizing Quasi Vivo® QV600 cell culture system for Liquid-Liquid interface applications
  • Serum-free Media FFM Part Codes
    2019 change of all RUO Media to FFM production overview of RUO and new FFM part codes (X-VIVO not included)
  • Quasi Vivo® Systems Part and Accessories List
    Quasi Vivo® System Starter Kits, Replacement Parts, and Alternative Accessories part list
  • 4D-Nucleofector® LV Unit for Large-scale Transfection
    Efficient, closed and scalable transfection for ex vivo cell and gene therapy applications
  • Primary Normal Human Cells and Media
    In Vivo Relevance. In Vitro Results. Updated and revised cell content. New in print
  • Brochure -- The Quasi Vivo® System - Fluidics for Primary Cell Culture
    The Quasi Vivo® System is an advanced interconnected cell culture flow system, specifically designed to provide a solution to the major problems researchers encounter when using conventional in vitro cell culture model systems.
  • Building Better In Vitro Models Using the Quasi Vivo® System
  • Developing Patient-specific Cell Therapy Manufacturing Processes
    Poster presentation about patient-specific cellular therapies and their tremendous potential for being able to treat life threatening diseases where there are currently no cures.
  • NK Cell Assay using 3D Bioprinted Tumor Models
    This white paper describes an ex vivo assay for NK cell killing activity in a 3D bioprinted cervical cancer tumor model.
  • A Non-Viral Method for Modifying and Expanding Primary T Cells
    Learn how Lonza’s Cocoon® Platform, 4D-Nucleofector™ LV Unit and X-VIVO™ 15 Medium are integrated to enable non-viral genetic modification and subsequent expansion of primary T cells in a functionally-closed, automated workflow.
  • A Novel In Vitro Liver Cell Culture Flow System Allowing Long-Term Metabolism and Hepatotoxicity Studies]
    Manuscript published in Applied In Vitro Toxicology journal describes improvement of CYP450 phenotype of primary cryopreserved hepatocytes using Quasi Vivo® System
  • Modeling a 3D respiratory model with the Quasi Vivo® QV600 Fluidic Cell Culture System
    In this Technical Note, we provide detailed information of how the Quasi Vivo® QV600 System was set up for the ALI culture of normal human bronchial or small airway epithelial (NHBE, SAE) cells.
  • Clonetics™ and Poietics™ Disease Cells
    In Vivo Relevance. In Vitro Results. Product listings on Poster Six disease cell lines are identified:Airway, Skeletal Muscle,Adipose, Cardiac, Renal and Dermal
  • 1(current)
  • 2
  • 3